The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs
- PMID: 3708213
- PMCID: PMC1917123
- DOI: 10.1111/j.1476-5381.1986.tb09481.x
The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs
Abstract
The release of platelet-activating factor (Paf-acether) and of its inactive precursor/metabolite lyso-platelet activating factor (lyso-Paf) from control and sensitized guinea-pig isolated lungs challenged with antigen was investigated. Control guinea-pig lungs perfused either through the pulmonary circulation or through the airways and challenged with antigen did not release Paf-acether. Sensitized guinea-pig isolated lungs perfused through the pulmonary circulation and challenged with antigen released lyso-Paf but not Paf-acether. Sensitized guinea-pig isolated lungs perfused through the airways and challenged with antigen released three times more lyso-Paf and also Paf-acether. These results support a possible role for Paf-acether in respiratory anaphylaxis in the guinea-pig.
Similar articles
-
The release of lyso-PAF from guinea-pig lungs.Eur J Pharmacol. 1985 Jun 7;112(2):281-4. doi: 10.1016/0014-2999(85)90511-4. Eur J Pharmacol. 1985. PMID: 4029263
-
Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.Eur J Pharmacol. 1987 Aug 21;140(3):311-21. doi: 10.1016/0014-2999(87)90288-3. Eur J Pharmacol. 1987. PMID: 3653247
-
Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.Am Rev Respir Dis. 1988 Dec;138(6):1572-8. doi: 10.1164/ajrccm/138.6.1572. Am Rev Respir Dis. 1988. PMID: 3202509
-
PAF-acether and experimental anaphylaxis as a model for asthma.Int Arch Allergy Appl Immunol. 1989;88(1-2):149-53. doi: 10.1159/000234770. Int Arch Allergy Appl Immunol. 1989. PMID: 2540093 Review.
-
Platelet-activating factor (PAF) and PAF antagonists in asthma.Crit Rev Ther Drug Carrier Syst. 1990;7(3):261-73. Crit Rev Ther Drug Carrier Syst. 1990. PMID: 2073689 Review.
Cited by
-
Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocytes into airways in actively sensitized conscious guinea pigs.Lipids. 1991 Dec;26(12):1305-9. doi: 10.1007/BF02536554. Lipids. 1991. PMID: 1819721
-
Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs.Br J Pharmacol. 1989 Jun;97(2):433-42. doi: 10.1111/j.1476-5381.1989.tb11970.x. Br J Pharmacol. 1989. PMID: 2474345 Free PMC article.
-
Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2.Inflammation. 1999 Oct;23(5):437-48. doi: 10.1023/a:1021913009742. Inflammation. 1999. PMID: 10466580
-
Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs.Br J Pharmacol. 1990 Feb;99(2):267-72. doi: 10.1111/j.1476-5381.1990.tb14692.x. Br J Pharmacol. 1990. PMID: 2328394 Free PMC article.
-
Platelet-activating factor in cardiovascular stress situations.Lipids. 1991 Dec;26(12):1257-63. doi: 10.1007/BF02536543. Lipids. 1991. PMID: 1819713 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical